|
1
|
Wülling M, Delling G and Kaiser E: The
origin of the neoplastic stromal cell in giant cell tumor of bone.
Hum Pathol. 34:983–993. 2003.PubMed/NCBI
|
|
2
|
Turcotte RE, Wunder JS, Isler MH, Bell RS,
Schachar N, Masri BA, Moreau G and Davis AM: Giant cell tumor of
long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res.
397:248–258. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yasuda H, Shima N, Nakagawa N, Yamaguchi
K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa
N, et al: A novel molecular mechanism modulating osteoclast
differentiation and function. Bone. 25:109–113. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takahashi N, Udagawa N and Suda T: A new
member of tumor necrosis factor ligand family,
ODFI/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and
function. Biochem Biophys Res Comm. 256:449–455. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu LZ and Yang WT: The criteria of
immunohistochemistry reaction results. China Oncology. 6:229–231.
1996.
|
|
6
|
Guo J, Wang Y, Ni J, Yang ZY, Huang JX and
Bai JZ: Expression and role of osteoclast differentiation
associated cytokine in giant cell tumors. Chinese J of CRTER.
11:242–246. 2007.
|
|
7
|
Meng XM, Yu SF and Wei MJ: Expression of
receptor activator of NF-kappa B ligand and osteoprotegerin protein
in the giant cell lesions of jaw. Chinese J of Stomatology.
40:294–297. 2005.(In Chinese).
|
|
8
|
Hu Y and Yu S: Gene expression of
osteoprotegerin and osteoclast differentiation factor in giant cell
tumor. Chinese J of Pathology. 31:128–131. 2002.PubMed/NCBI
|
|
9
|
Liu B, Yu SF and Li TJ: Multinucleated
giant cells in various forms of giant cell containing lesions of
the jaws express features of osteoclasts. J Oral Pathol Med.
32:367–375. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Atkins GJ, Haynes DR, Graves SE, Evdokiou
A, Hay S, Bouralexis S and Findlay DM: Expression of osteoclast
differentiation signals by stromal elements of giant cell tumor. J
Bone Miner Res. 15:640–649. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang L, Xu J, Wood DJ and Zheng MH: Gene
expression of osteoprotegerin ligand, osteoprotegerin, and receptor
activator of NF-kappaB in giant cell tumor of bone: possible
involvement in tumor cell-induced osteoclast-like cell formation.
Am J Pathol. 156:761–767. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roux S, Amazit L, Meduri G,
Guiochon-Mantel A, Milgrom E and Mariette X: RANK (receptor
activator of nuclear factor kappa B) and RANK ligand are expressed
in giant cell tumors of bone. Am J Clin Pathol. 117:210–216. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu Y, Dong SK and Fan QH: Expression of
osteoclast differentiation factor and its receptor and decoy
receptor in giant cell tumor of bone. J Southeast Univ (Medical
Science Edition). 24:330–333. 2005.
|
|
14
|
Thompson SH, Bischoff P and Bender S:
Central giant cell granuloma of the mandible. J Oral Maxillofac
Surg. 41:743–746. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu B, Yu SF and Pang SZ: Purification and
study of the characteristics of the multinucleated giant cells of
the giant cell tumor. Journal of Peking University (Health
Sciences). 35:23–27. 2003.(In Chinese).
|
|
16
|
Atkins GJ, Kostakis P, Vincent C, Farrugia
AN, Houchins JP, Findlay DM, Evdokiou A and Zannettino AC: RANK
expression as a cell surface marker of human osteoclast precursors
in peripheral blood, bone marrow, and giant cell tumors of bone. J
Bone Miner Res. 21:1339–1349. 2006. View Article : Google Scholar : PubMed/NCBI
|
